Molecular Formula | C7H12Cl2N2O |
Molar Mass | 211.09 |
Melting Point | 138-140°C(lit.) |
Boling Point | 357.7°C at 760 mmHg |
Flash Point | 170.1°C |
Water Solubility | Soluble 50 MG/ML |
Solubility | H2O: 50mg/mL, slightly hazy, faintly yellow |
Vapor Presure | 1.3E-05mmHg at 25°C |
Appearance | Adhering Powder |
Color | Off-white to beige |
BRN | 9282965 |
Storage Condition | 2-8°C |
Hazard Symbols | Xi - Irritant |
Risk Codes | 36/37/38 - Irritating to eyes, respiratory system and skin. |
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36 - Wear suitable protective clothing. |
WGK Germany | 3 |
FLUKA BRAND F CODES | 10 |
HS Code | 29280090 |
Overview | 3-hydroxybenzine is often widely used as a behavioral research substance that inhibits AADC activity and L-DOPA effects on motor function. It is reported in the literature that the use of 3-hydroxybenzine to inhibit the activity of central AAD can increase the accumulation of endogenous L-DOPA and enhance the autonomous activity of quinpirole, a D2 receptor agonist in normal mice. |
Use | Experiments have shown that 3-hydroxybenzine can inhibit the reversal of motor defects in the treatment of MPTP-induced primate Parkinson's disease with L-DOPA. |